Article

sacbee.com on 2023-12-15 14:00

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus (RSV) Vaccine

Moderna has submitted marketing authorizations globally for mRNA-1345 and continues to prepare for an expected 2024 marketing launch

Related news

CPhase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting charlotteobserver.com
Phase 1
Respiratory syncytial virus spreading quickly this year whnt.com
Regeneron scraps development of drug for respiratory syncytial virus westfaironline.com
France
What Is Respiratory Syncytial Virus And Why It Matters Now Forbes
United States , Washington
TFive Questions About the Surging Outbreak of Respiratory Syncytial Virus today.uconn.edu
RL.A. County Supervisors Act to Curb Rising Respiratory Syncytial Virus Rates randomlengthsnews.com
New Research Provides Hope In The Search For A Respiratory Syncytial Virus Vaccine- Part III Forbes
VInfluenza continues to decline in B.C.; respiratory syncytial virus remains high; COVID-19 remains relatively stable voiceonline.com
Vancouver International Airport
BCOVID-19: New studies show AstraZeneca’s efficacy matches mRNA vaccines businessday.ng
Nigeria , Vietnam , Brazil , Asia
90% efficacy for Pfizer's COVID-19 mRNA vaccine is striking timesofmalta.com
Malta , Australia , Australia , Germany
G2022 Global Respiratory Syncytial Virus (RSV) Therapeutics Industry Status and Prospects Professional Market Research Report Standard Version galleonnews.com
United States , New York , 5th Avenue , South America , Oceania
GGlobal Respiratory Syncytial Virus Fusion Protein Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 galleonnews.com
Sinovac vaccine efficacy against Omicron increases following mRNA booster, Yale study finds yaledailynews.com
New Haven , York Street , Brazil , United States , China
CModerna and OpenAI Collaborate To Advance mRNA Medicine charlotteobserver.com
CModerna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress charlotteobserver.com
United Kingdom , Spain , Infectious Diseases
MModerna (MRNA) Q3 Outcomes 2022 mvtelegraph.com
Wall Street
AstraZeneca buys respiratory drug business The Toledo Blade
Japan
AVirginia becomes 11th state to allow terminally ill to access investigational medications augustafreepress.com
Mississippi , Wyoming , Utah , South Dakota , Missouri
AColleges, universities show efficacy of vaccine mandates augustafreepress.com
Appalachian Trail , Shenandoah National Park , Skyline Drive , Blue Ridge Parkway , Waynesboro
OSHA Approves New Respiratory Fit Testing Protocols jdsupra.com
California , United States , Switzerland